How the Skeletal System Uses Hematopoiesis to Support the Body

The skeleton does far more than hold you upright. Inside the cavities of your bones, a spongy tissue called bone marrow continuously manufactures the red blood cells that carry oxygen, the white blood cells that fight infection, and the platelets that stop bleeding. This process, hematopoiesis, is one of the most prolific production lines in the human body, churning out hundreds of billions of new blood cells every day. What makes the relationship especially interesting is that it runs in both directions: bone cells don’t just provide passive shelter for blood-cell factories, they actively regulate which cells get made, how many, and when.

Why Blood Is Made Inside Bones

For most of vertebrate evolutionary history, blood cells were produced in the liver and kidneys. The shift to bone marrow happened as vertebrates moved onto land, and it may not have been accidental. A recent analysis proposes that housing blood stem cells inside bone reduced their exposure to background ionizing radiation by at least 20 percent, with additional protection coming from the low-oxygen conditions inside marrow cavities, since oxygen amplifies radiation-induced DNA damage.¹ Given that blood stem cells are especially sensitive to radiation and need to last a lifetime, even a modest drop in DNA damage could have offered a meaningful survival advantage over millions of years.

That low-oxygen environment turns out to be more than just a radiation shield. Hematopoietic stem cells in the marrow deliberately rely on anaerobic metabolism, generating their energy through glycolysis rather than the oxygen-hungry pathways most cells prefer.² This keeps the production of reactive oxygen species low, which in turn protects the stem cells’ DNA from oxidative damage.³ In effect, the interior of bone is a carefully maintained quiet room: shielded, oxygen-poor, and metabolically calm, all to keep stem cells in good shape for decades.

The Marrow Niche and How Bone Cells Run the Show

Blood stem cells don’t just float freely inside your bones. They anchor themselves in highly specific neighborhoods called niches, located mainly near the inner bone surface and around the tiny blood vessels that thread through the marrow. These niches are primarily created by two cell types: mesenchymal stromal cells and the endothelial cells that line blood vessels, often positioned near the spongy trabecular bone found inside hips, vertebrae, and the ends of long bones.⁴

Cells of the osteoblast lineage, which are the bone-forming cells at various stages of maturity, play a particularly active role. From immature skeletal stem cells all the way to the osteocytes embedded deep within mineralized bone, these cells produce signaling molecules that influence whether blood stem cells stay dormant, divide, or commit to becoming a particular type of blood cell.⁵ Meanwhile, osteoclasts, the cells that break down bone, serve a dual purpose. By resorbing bone tissue, they remodel the inner surface of the bone cavity and, in doing so, free stem cells from their anchored positions, allowing them to enter the bloodstream when the body needs a surge of new blood cells.⁶

This means that bone remodeling, the constant cycle of breaking down and rebuilding bone that keeps your skeleton strong, is simultaneously reshaping the environment where blood cells are made. The two processes are not just neighbors; they’re mechanically and chemically entangled.

Making Red Blood Cells

Of all the blood cells produced through hematopoiesis, red blood cells demand the most effort. Your body produces roughly two million of them every second to maintain oxygen delivery to tissues. The process of making them, erythropoiesis, relies on a striking anatomical arrangement inside the marrow called the erythroblastic island. Each island consists of a central macrophage surrounded by a ring of developing red blood cell precursors called erythroblasts.⁷

The macrophage at the center isn’t just sitting there. It provides nutrients and survival signals to the surrounding erythroblasts, helps coordinate their loading with hemoglobin, and at the very end of the process, eats the nuclei that the maturing red blood cells expel before entering the bloodstream.⁸ Iron supply is a central part of this arrangement: the macrophages coordinate the delivery of iron to their ring of erythroblasts, since iron is essential for building hemoglobin.⁹

Once the young red blood cells are mature enough, they need to cross into the bloodstream. The sinusoidal blood vessels inside the marrow control this final gate. Research in mice has shown that when the endothelial cells lining these sinusoids malfunction, immature red blood cells pile up outside the vessel walls and fail to complete their final maturation steps, leading to a shortage of circulating mature red cells.¹⁰ The skeleton, in other words, doesn’t just produce red blood cells. Its internal vascular plumbing also acts as quality control.

Where Your Immune System Gets Built

Bone marrow is the birthplace of essentially every immune cell in your body. White blood cells of all types, from the neutrophils that are first responders to infection to the lymphocytes that remember pathogens for years, trace their origins to stem cells sitting inside bone. But the marrow does more than just launch these cells into circulation. For B lymphocytes, the cells responsible for producing antibodies, the marrow provides a series of distinct microenvironments that guide each stage of development.

Early B cell precursors attach to stromal cells that produce a signaling molecule called CXCL12. As the B cells mature, they physically migrate away from those cells and toward a different set of stromal cells producing a growth factor called IL-7. Once the B cells are fully mature and have left the marrow, some return later in life as antibody-secreting plasma cells and re-anchor to those same CXCL12-producing stromal cells.¹¹ The bone marrow thus serves as both nursery and retirement home for the B cell lineage.

Those returning plasma cells can survive for decades inside the marrow, continuously secreting antibodies against infections you encountered years or even decades ago. They are kept alive by a dedicated survival niche involving stromal cells and a rotating cast of other immune cells, including eosinophils, that provide the signals plasma cells need to persist.¹² This is one reason your immunity to certain childhood infections can last a lifetime: the bone marrow physically maintains the cells that remember them.

Platelet Production and Blood Clotting

Platelets, the cell fragments that clump together to form clots at wound sites, are made by enormous cells in the marrow called megakaryocytes. A single megakaryocyte can release thousands of platelets by extending long, branching projections into the marrow’s sinusoidal blood vessels and shedding fragments directly into the flowing blood.¹³ This means platelets are one of the few blood components that enter circulation already inside a blood vessel, rather than having to cross a vessel wall. Conditions that damage the bone marrow, whether from chemotherapy, radiation, or diseases like leukemia, frequently cause dangerously low platelet counts precisely because the marrow is the only production site.

Emergency Mode

Under normal conditions, hematopoiesis runs at a steady pace. But severe infections, major injuries, or heavy blood loss can trigger what researchers call emergency hematopoiesis, a rapid shift in marrow output to meet sudden demand. During trauma, inflammatory signals, particularly a cytokine called IL-1, drive the marrow to expand its pool of immature blood cell progenitors and skew their output toward the myeloid cells (neutrophils, monocytes) that the body urgently needs to fight infection and clean up damaged tissue.¹⁴

Infection triggers a similar response but with its own complications. In chronic infections, the sustained activation of stem cells can actually reshape marrow output in unhelpful ways. Research on visceral leishmaniasis, a parasitic infection, showed that the pathogen itself drives stem cell expansion and biases the new cells toward a regulatory phenotype that suppresses the immune response, essentially hijacking the emergency system to benefit the parasite.¹⁵

To fuel this sudden ramp-up, stem cells change their metabolism. Under infection pressure, they begin importing fatty acids from their surroundings and burning them for energy, a shift from the quiet, glycolysis-based metabolism they normally prefer.¹⁶ The marrow environment’s fat stores, which are abundant in adults, likely provide the raw material.

The Crosstalk Between Red Blood Cells and Bone Density

Erythropoietin (EPO), the hormone that stimulates red blood cell production, also binds to receptors on osteoblasts. This dual signaling creates a direct link between how aggressively your body makes red blood cells and what happens to your bone density. In mice, when EPO signaling was removed specifically from osteoblasts, both males and females lost significant trabecular bone volume over time, with males losing about 22 percent and females about 30 percent by 12 weeks.¹⁷ When EPO was given at high doses to stimulate red blood cell production, it caused bone loss in normal mice but not in mice lacking the EPO receptor on osteoblasts.

This has practical implications. Patients who receive EPO therapy for chronic anemia, a common treatment in kidney disease, may face an increased risk of bone fractures because the same hormone driving their red blood cell production is also accelerating bone resorption.¹⁸ The skeleton and the blood system aren’t just sharing space. They’re competing for resources, and pushing one system harder can strain the other.

Hormones, Nerves, and the Clock

The bone marrow niche doesn’t operate autonomously. It receives instructions from the nervous system, from hormones, and even from the body’s internal clock. Parathyroid hormone (PTH), best known for regulating calcium levels and bone turnover, also expands the bone marrow stem cell niche and, when delivered intermittently, can mobilize progenitor cells out of the marrow and into the bloodstream.¹⁹

The nervous system has its own lever. Sympathetic nerve fibers that innervate the bone marrow release noradrenaline on a circadian cycle, controlled by the body’s core clock genes. This rhythmic noradrenaline signal acts on stromal cells through a specific receptor, causing them to reduce production of CXCL12, the anchoring molecule that holds stem cells in place. The result is that stem cell release into the bloodstream fluctuates over the course of the day.²⁰ This is one reason blood cell counts measured in the morning can differ from those taken in the evening, and it has practical implications for the timing of blood draws and stem cell harvests in clinical settings.

What Changes as You Age

At birth, virtually all your bone marrow is red marrow, actively producing blood cells. Over the first two decades of life, much of it converts to yellow marrow, which is mostly fat, retreating to the central skeleton: the pelvis, spine, ribs, sternum, and the ends of the femur and humerus. This process can reverse under stress, a phenomenon called reconversion, where yellow marrow reverts to red to meet increased demand for blood cells.²¹

But with advancing age, the balance tips further toward fat. Bone marrow fat content increases, and the number of blood stem cells declines in tandem. Levels of growth factors like IGF-1 and the stem cell anchoring molecule SDF-1 also drop as marrow fat rises.²² The fat cells themselves become part of the problem. Aging marrow adipocytes shift their secretory profile, pumping out more inflammatory signals and less of the supportive hormones they produced when younger. This pushes the remaining stem cells to produce more myeloid cells (the innate immune responders) and fewer lymphoid cells (the adaptive immune fighters), which may help explain why older adults are more susceptible to infections and respond less robustly to vaccines.²³

Obesity accelerates this process. Excess marrow fat, whether from aging or from metabolic disease, impairs both blood cell regeneration and bone healing. Research has identified a protease called DPP-4, which is overproduced by marrow adipocytes and is already a pharmaceutical target for type 2 diabetes, as a potential mediator of this damage.²⁴ The overlap between metabolic health and blood production is wider than most people realize.

Exercise, Diet, and the Marrow Environment

Physical activity directly influences the bone marrow environment. Mechanical loading from locomotion is sensed by mesenchymal stem cells and osteocytes inside bone, and these mechanical signals promote the migration, proliferation, and differentiation of stem cells in ways that help maintain bone mass.²⁵ While much of this research has focused on bone density, the implication for hematopoiesis is that a more robust bone microenvironment likely supports healthier blood cell production as well, since the niche cells are shared between the two systems.

Dietary intake also shapes marrow output. Moderate calorie restriction has been shown to enhance the repopulation capacity of blood stem cells, meaning they become better at rebuilding the blood system after a challenge. However, that same restriction impairs the differentiation of stem cells into lymphoid cells, the arm of the immune system responsible for targeted responses to specific pathogens.²⁶ This trade-off suggests that the marrow environment reads the body’s energy status and adjusts blood cell production accordingly, prioritizing stem cell maintenance during scarcity while potentially sacrificing some immune capability.

What Transplantation Reveals

Bone marrow transplantation, one of the most dramatic procedures in modern medicine, works precisely because of the skeletal system’s role in hematopoiesis. When a patient’s marrow is destroyed by high-dose chemotherapy or radiation, donor stem cells injected into the bloodstream have to find their way back into the bone marrow niches and anchor themselves there before they can begin producing new blood cells. This process, called homing, is a complex multi-step migration involving signaling molecules, adhesion receptors, and the physical architecture of the marrow’s blood vessels.²⁷

Homing and the subsequent engraftment, where the transplanted cells begin proliferating, are functionally separate processes. A transplanted cell can reach the marrow but fail to engraft, or engraft but produce an abnormal mix of blood cells. The success of the transplant depends entirely on the health and receptivity of the bone marrow niche. Damage to the niche from prior radiation, aging, or disease is a major reason some transplants fail or produce incomplete immune recovery. Clinicians increasingly recognize that preparing the niche, not just the stem cells, is critical to transplant success.